Bundamedik Tbk PT
IDX:BMHS
Balance Sheet
Balance Sheet Decomposition
Bundamedik Tbk PT
Bundamedik Tbk PT
Balance Sheet
Bundamedik Tbk PT
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
98 879
|
90 657
|
619 379
|
818 112
|
590 555
|
170 822
|
295 860
|
|
| Cash |
98 879
|
90 657
|
619 379
|
818 112
|
590 555
|
170 822
|
295 860
|
|
| Short-Term Investments |
3 754
|
9 598
|
5 607
|
33 774
|
47 367
|
457 002
|
490 734
|
|
| Total Receivables |
85 903
|
99 049
|
160 071
|
208 672
|
150 547
|
137 160
|
174 760
|
|
| Accounts Receivables |
37 913
|
61 849
|
123 131
|
156 760
|
114 644
|
110 469
|
144 714
|
|
| Other Receivables |
47 989
|
37 199
|
36 940
|
51 912
|
35 904
|
26 691
|
30 046
|
|
| Inventory |
10 286
|
16 229
|
18 986
|
38 895
|
39 449
|
42 198
|
47 022
|
|
| Other Current Assets |
18 758
|
15 565
|
11 691
|
31 653
|
59 911
|
61 864
|
80 504
|
|
| Total Current Assets |
217 580
|
231 097
|
815 734
|
1 131 106
|
887 830
|
869 046
|
1 088 881
|
|
| PP&E Net |
988 015
|
1 124 340
|
1 273 019
|
1 559 679
|
1 844 114
|
1 966 240
|
2 029 431
|
|
| PP&E Gross |
988 015
|
1 124 340
|
1 273 019
|
1 559 679
|
1 844 114
|
1 966 240
|
2 029 431
|
|
| Accumulated Depreciation |
202 776
|
241 109
|
269 235
|
348 152
|
491 520
|
582 125
|
683 158
|
|
| Goodwill |
0
|
0
|
0
|
50 812
|
94 794
|
94 794
|
94 794
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
38
|
|
| Long-Term Investments |
6 500
|
22 765
|
48 543
|
21 495
|
78 690
|
83 196
|
89 777
|
|
| Other Long-Term Assets |
29 056
|
22 556
|
25 241
|
50 605
|
33 183
|
69 887
|
143 441
|
|
| Other Assets |
0
|
0
|
0
|
50 812
|
94 794
|
94 794
|
94 794
|
|
| Total Assets |
1 241 151
N/A
|
1 400 758
+13%
|
2 162 537
+54%
|
2 813 697
+30%
|
2 938 610
+4%
|
3 083 162
+5%
|
3 446 361
+12%
|
|
| Liabilities | ||||||||
| Accounts Payable |
89 227
|
74 678
|
120 125
|
119 160
|
91 788
|
55 771
|
30 882
|
|
| Accrued Liabilities |
12 303
|
9 362
|
28 134
|
43 396
|
27 025
|
30 345
|
28 574
|
|
| Short-Term Debt |
0
|
0
|
391 718
|
391 718
|
391 718
|
411 753
|
440 600
|
|
| Current Portion of Long-Term Debt |
50 968
|
74 887
|
34 427
|
50 920
|
81 739
|
19 770
|
23 387
|
|
| Other Current Liabilities |
45 303
|
99 655
|
108 812
|
131 304
|
51 592
|
51 993
|
44 973
|
|
| Total Current Liabilities |
197 801
|
258 582
|
683 216
|
736 497
|
643 862
|
569 632
|
568 416
|
|
| Long-Term Debt |
482 690
|
443 214
|
386 009
|
229 437
|
457 963
|
688 431
|
699 941
|
|
| Deferred Income Tax |
0
|
0
|
115
|
136
|
18
|
0
|
641
|
|
| Minority Interest |
37 450
|
47 012
|
54 462
|
245 476
|
212 082
|
210 223
|
434 256
|
|
| Other Liabilities |
28 431
|
33 368
|
43 498
|
51 410
|
28 535
|
25 064
|
29 627
|
|
| Total Liabilities |
746 373
N/A
|
782 176
+5%
|
1 167 300
+49%
|
1 262 957
+8%
|
1 342 459
+6%
|
1 493 349
+11%
|
1 732 882
+16%
|
|
| Equity | ||||||||
| Common Stock |
1 000
|
1 000
|
150 000
|
172 068
|
172 068
|
172 068
|
172 068
|
|
| Retained Earnings |
24 272
|
17 049
|
83 742
|
242 067
|
303 295
|
297 851
|
304 976
|
|
| Additional Paid In Capital |
74 441
|
74 441
|
74 441
|
449 168
|
437 383
|
437 383
|
556 675
|
|
| Unrealized Security Profit/Loss |
448 094
|
564 306
|
690 499
|
690 499
|
690 499
|
690 499
|
690 499
|
|
| Other Equity |
4 485
|
4 115
|
3 445
|
3 063
|
7 095
|
7 988
|
10 740
|
|
| Total Equity |
494 778
N/A
|
618 582
+25%
|
995 237
+61%
|
1 550 740
+56%
|
1 596 151
+3%
|
1 589 813
0%
|
1 713 479
+8%
|
|
| Total Liabilities & Equity |
1 241 151
N/A
|
1 400 758
+13%
|
2 162 537
+54%
|
2 813 697
+30%
|
2 938 610
+4%
|
3 083 162
+5%
|
3 446 361
+12%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
8 541
|
8 541
|
8 541
|
8 603
|
8 603
|
8 603
|
8 603
|
|